As on Wednesday, Context Therapeutics Inc (NASDAQ: CNTX) got off with the flyer as it spiked 11.50% to $2.23, before settling in for the price of $2.00 at the close. Taking a more long-term approach, CNTX posted a 52-week range of $0.77-$2.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was -26.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 77.83%. This publicly-traded company’s shares outstanding now amounts to $75.00 million, simultaneously with a float of $59.34 million. The organization now has a market capitalization sitting at $167.25 million. At the time of writing, stock’s 50-day Moving Average stood at $2.17, while the 200-day Moving Average is $1.73.
Context Therapeutics Inc (CNTX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Context Therapeutics Inc’s current insider ownership accounts for 20.88%, in contrast to 56.62% institutional ownership.
Context Therapeutics Inc (CNTX) Earnings and Revenue Records
Context Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 77.83% and is forecasted to reach -0.30 in the upcoming year.
Context Therapeutics Inc (NASDAQ: CNTX) Trading Performance Indicators
Let’s observe the current performance indicators for Context Therapeutics Inc (CNTX). It’s Quick Ratio in the last reported quarter now stands at 64.01. The Stock has managed to achieve an average true range (ATR) of 0.18.
In the same vein, CNTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.06, a figure that is expected to reach -0.09 in the next quarter, and analysts are predicting that it will be -0.30 at the market close of one year from today.
Technical Analysis of Context Therapeutics Inc (CNTX)
Through scrutinizing the latest numbers posted by the [Context Therapeutics Inc, CNTX], it can be observed that its last 5-days Average volume of 0.58 million was better the volume of 0.31 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 74.69% While, its Average True Range was 0.19.
Raw Stochastic average of Context Therapeutics Inc (CNTX) in the period of the previous 100 days is set at 62.80%, which indicates a major rise in contrast to 61.71% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 88.00% that was higher than 74.77% volatility it exhibited in the past 100-days period.
